AltaThera is a precision medicine company using innovative science to improve patient care and solve serious and costly problems.
We are working to narrow the gap between scientific innovation and clinical decision-making by individualizing cardiovascular drug treatment for diverse patient populations.
There’s a global arrhythmia epidemic with
34 million suffering from Atrial Fibrillation.
6 million patients in the U.S. today will grow to 12 million patients in 10 years. Our first product, Sotalol IV, a new formulation of a widely used and trusted antiarrhythmic drug, shortens hospital stay by converting an inpatient procedure to an outpatient procedure.
Our models help to find novel ways of using existing drugs by analyzing clinical data.
Grow your career and change lives. If you’re passionate about having an impact on medicine, we’d love to hear from you.
Fill out this form and we’ll be in touch.